Neonc Technologies Holdings, Inc.

NTHI Biotech & pharma

Develops drugs for brain cancers.

Dec 2025Revenue $40.0K/yrExpenses $58.3M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year

When will Neonc Technologies Holdings be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $40.0K and expenses $58.3M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$40.0K$58.3M−$58.2M
Dec 2024$83.0K$7.23M−$7.14M